30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

PATEL DINESH V PH D

Insider profile

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
18 0% Buy
34 71% Buy
47 69% Buy
PATEL DINESH V PH D's trades of Protagonist Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-12 2026-05-12 S Sale
11,101 -21.6%
187.58
US$3,872,399
11,101 -21.6% 187.58 US$3,872,399
2026-05-12 2026-05-12 PrS Proposed sale
65,506
357.17
US$3,311,639
65,506 357.17 US$3,311,639
2026-03-25 2026-03-25 S Sale
67,033 -6.8%
234.51
US$2,940,363
67,033 -6.8% 234.51 US$2,940,363
2026-03-25 2026-03-24 S Sale
59 -0.0%
101.00
US$5,959
59 -0.0% 101.00 US$5,959
2026-03-24 2026-03-24 PrS Proposed sale
54,700
98.54
US$5,390,138
54,700 98.54 US$5,390,138
2026-01-27 2026-01-27 S Sale
4,068 -0.7%
83.19
US$338,417
4,068 -0.7% 83.19 US$338,417
2026-01-27 2026-01-26 S Sale
14,205 -2.4%
84.05
US$1,193,930
14,205 -2.4% 84.05 US$1,193,930
2026-01-27 2026-01-26 S Sale
10,685 -1.8%
84.00
US$897,540
10,685 -1.8% 84.00 US$897,540
2026-01-27 2026-01-23 S Sale
19,315 -3.3%
84.59
US$1,633,856
19,315 -3.3% 84.59 US$1,633,856
2026-01-23 2026-01-23 PrS Proposed sale
108,273
84.62
US$9,162,061
108,273 84.62 US$9,162,061
2026-01-21 2026-01-20 PrS Proposed sale
34,438
82.48
US$2,840,446
34,438 82.48 US$2,840,446
2026-01-21 2026-01-20 S Sale
34,438 -5.6%
82.48
US$2,840,446
34,438 -5.6% 82.48 US$2,840,446
2025-07-28 2025-07-25 S Sale
10,415 -2.0%
54.78
US$570,534
10,415 -2.0% 54.78 US$570,534
2025-07-23 2025-07-23 S Sale
17,520 -3.2%
54.79
US$959,921
17,520 -3.2% 54.79 US$959,921
2025-07-23 2025-07-22 S Sale
22,065 -3.9%
55.05
US$1,214,678
22,065 -3.9% 55.05 US$1,214,678
2025-07-22 2025-07-22 PrS Proposed sale
50,000
55.22
US$2,761,000
50,000 55.22 US$2,761,000
2025-07-23 2025-07-21 S Sale
12,859 -2.2%
54.86
US$705,445
12,859 -2.2% 54.86 US$705,445
2025-02-20 2025-02-19 S Sale
5,359 -1.0%
38.18
US$204,607
5,359 -1.0% 38.18 US$204,607
2024-11-27 2024-11-26 S Sale
21,480 -5.0%
46.25
US$993,450
21,480 -5.0% 46.25 US$993,450
2024-11-27 2024-11-25 PlS Planned sale
78,520 -15.3%
46.96
US$3,687,299
78,520 -15.3% 46.96 US$3,687,299
2024-11-25 2024-11-25 PrS Proposed sale
100,000
45.93
US$4,593,000
100,000 45.93 US$4,593,000
2024-06-11 2024-06-07 PlS Planned sale
35,000 -6.4%
35.19
US$1,231,650
35,000 -6.4% 35.19 US$1,231,650
2024-06-07 2024-06-07 PrS Proposed sale
35,000
33.72
US$1,180,200
35,000 33.72 US$1,180,200
2024-04-02 2024-04-01 PlS Planned sale
25,000 -4.4%
28.31
US$707,750
25,000 -4.4% 28.31 US$707,750
2024-04-01 2024-04-01 PrS Proposed sale
25,000
28.77
US$719,250
25,000 28.77 US$719,250
2024-03-01 2024-03-01 PrS Proposed sale
90,000
31.62
US$2,846,151
90,000 31.62 US$2,846,151
2024-03-01 2024-03-01 PlS Planned sale
30,000 -5.0%
31.62
US$948,600
30,000 -5.0% 31.62 US$948,600
2023-12-15 2023-12-13 PlS Planned sale
75,000 -12.3%
20.08
US$1,506,000
75,000 -12.3% 20.08 US$1,506,000
2023-12-13 2023-12-13 PrS Proposed sale
75,000
20.08
US$1,506,075
75,000 20.08 US$1,506,075
2021-12-23 2021-12-21 S Sale
15,000 -3.0%
32.14
US$482,170
15,000 -3.0% 32.14 US$482,170
2021-01-20 2021-01-19 PlS Planned sale
24,846 -5.5%
24.60
US$611,105
24,846 -5.5% 24.60 US$611,105
2019-03-04 2019-03-01 S Sale
2,183 -0.6%
8.03
US$17,529
2,183 -0.6% 8.03 US$17,529
2019-02-08 2019-02-06 S Sale
10,132 -2.8%
7.71
US$78,118
10,132 -2.8% 7.71 US$78,118
2019-02-08 2019-02-06 S Sale
777 -0.2%
8.10
US$6,292
777 -0.2% 8.10 US$6,292